Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia

被引：0
|
作者：
Mendez, Raul [1 ,2 ,3 ,4 ]
Gonzalez-Jimenez, Paula [1 ,2 ,3 ]
Mengot, Noe [1 ,2 ]
Menendez, Rosario [1 ,2 ,3 ,4 ,5 ]
机构：
[1] La Fe Univ & Polytech Hosp, Pneumol Dept, Valencia, Spain
[2] Hlth Res Inst La Fe IISLAFE, Resp Infect, Valencia, Spain
[3] Univ Valencia, Dept Med, Valencia, Spain
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Serv Neumol, Avda Fernando Abril Martorell 106, Valencia 46026, Spain
来源：
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 45卷 / 02期
关键词：
CAP; inflammatory-immune response; microbiologic treatment; RESPIRATORY-DISTRESS-SYNDROME; INFECTIOUS-DISEASES-SOCIETY; LENGTH-OF-STAY; HOSPITALIZED-PATIENTS; ANTIBIOTIC-TREATMENT; THORACIC-SOCIETY; RISK-FACTORS; EARLY SWITCH; TIME; OUTCOMES;
D O I：
10.1055/s-0043-1778139
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Treatment failure and clinical stability are important outcomes in community-acquired pneumonia (CAP). It is essential to know the causes and risk factors for treatment failure and delay in reaching clinical stability in CAP. The study of both as well as the associated underlying mechanisms and host response are key to improving outcomes in pneumonia.
引用
收藏
页码：225 / 236
页数：12
相关论文
共 50 条
  • [21] Macrolide treatment failure in community-acquired pneumonia and associated clinical consequences
    Wu, JH
    McGowan, JE
    Howard, MH
    Frau, LM
    Dai, WS
    CHEST, 2004, 126 (04) : 736S - 737S
  • [22] Severe community-acquired pneumonia
    So, HY
    ANAESTHESIA AND INTENSIVE CARE, 1997, 25 (03) : 222 - 234
  • [23] Severe community-acquired pneumonia
    Torres, A
    ElEbiary, M
    Zavala, E
    Hernandez, C
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 17 (03) : 265 - 271
  • [24] Early prediction of treatment failure in severe community-acquired pneumonia: The PRoFeSs score
    Pereira, Jose Manuel
    Laszczynska, Olga
    Azevedo, Ana
    Basilio, Carla
    Sousa-Dias, Conceicao
    Mergulhao, Paulo
    Paiva, Jose Artur
    JOURNAL OF CRITICAL CARE, 2019, 53 : 38 - 45
  • [25] Clinical presentations and outcome of severe community-acquired pneumonia
    Elshamly, Mousa
    Nour, Mohamed O.
    Omar, Abdelmaaboud M. M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2016, 65 (04): : 831 - 839
  • [26] SEVERE COMMUNITY-ACQUIRED PNEUMONIA - ETIOLOGY, PROGNOSIS, AND TREATMENT
    PACHON, J
    PRADOS, MD
    CAPOTE, F
    CUELLO, JA
    GARNACHO, J
    VERANO, A
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (02): : 369 - 373
  • [27] Pharmacoeconomic analysis of severe community-acquired pneumonia treatment
    Kulikov, A.
    Krysanov, I
    VALUE IN HEALTH, 2007, 10 (03) : A165 - A165
  • [28] Combination Antibiotic Treatment of Severe Community-Acquired Pneumonia
    Janet R. Maurer
    Current Infectious Disease Reports, 2011, 13 (3) : 207 - 209
  • [29] Time to Clinical Stability in Children With Community-Acquired Pneumonia
    Field, Madeline R.
    Ambroggio, Lilliam
    Lorenz, Douglas
    Shah, Samir S.
    Ruddy, Richard M.
    Florin, Todd A.
    PEDIATRICS, 2024, 153 (05)
  • [30] Clinical Stability and Biomarkers in Community-Acquired Pneumonia.
    Menendez, R.
    Reyes, S.
    Martinez, R.
    Esquinas, C.
    Piner, R.
    Martinez, A.
    Mensa, J.
    Filella, X.
    Torres, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345